The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Prevalence, mechanisms, and management of cancer-related cognitive impairment
Open accessAbstract
This review summarizes the current literature on cancer-related cognitive impairment (CRCI) with a focus on prevalence, mechanisms, and possible interventions for CRCI in those who receive adjuvant chemotherapy for non-central nervous system tumours and is primarily focused on breast cancer. CRCI is characterized as deficits in areas of cognition including memory, attention, concentration, and executive function. Development of CRCI can impair quality of life and impact treatment decisions. CRCI is highly prevalent; these problems can be detected in up to 30% of patients prior to chemotherapy, up to 75% of patients report some form of CRCI during treatment, and CRCI is still present in up to 35% of patients many years following completion of treatment. While the trajectory of CRCI is becoming better understood, the mechanisms underlying the development of CRCI are still obscure; however, host characteristics, immune dysfunction, neural toxicity, and genetics may play key roles in the development and trajectory of CRCI. Intervention research is limited, though strategies to maintain function are being studied with promising preliminary findings. This review highlights key research being conducted in these areas, both in patient populations and in animals, which will ultimately result in better understanding and effective treatments for CRCI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Han, R., Yang, Y. M., Dietrich, J., Luebke, A., Mayer-Pröschel, M., & Noble, M. (2008) · Journal of Biology · doi:10.1186/jbiol69 · Cited by 316
Cognitive Training for Improving Executive Function in Chemotherapy-Treated Breast Cancer Survivors
Kesler, S., Hadi Hosseini, S. M., Heckler, C., Janelsins, M., Palesh, O., Mustian, K., & Morrow, G. (2013) · Clinical Breast Cancer · doi:10.1016/j.clbc.2013.02.004 · Cited by 300
Self-citationPalmer, J. L., Trotter, T., Joy, A. A., & Carlson, L. E. (2008) · Journal of Cancer Survivorship · doi:10.1007/s11764-008-0070-1 · Cited by 89 · cited 1×
“…therapies both show declines compared to healthy controls, suggesting that hormone therapies can also lead to CRCI (Ahles et al., 2010), and the combined treatment of tamoxifen and chemotherapy leads to greater diffi culties than chemotherapy alone (Castellon et al., 2004; Palmer et al., 2008).”
Background
Cited by
One in two cancer patients is significantly distressed: Prevalence and indicators of distress
Mehnert, A., Hartung, T. J., Friedrich, M., Vehling, S., Brähler, E., Härter, M., Keller, M., Schulz, H., Wegscheider, K., Weis, J., et al. (2018) · Psycho-Oncology · doi:10.1002/pon.4464 · Cited by 615
Management of common clinical problems experienced by survivors of cancer
Emery, J., Butow, P., Lai-Kwon, J., Nekhlyudov, L., Rynderman, M., & Jefford, M. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00242-2 · Cited by 326
Hartman, S. J., Nelson, S. H., Myers, E., Natarajan, L., Sears, D. D., Palmer, B. W., Weiner, L. S., Parker, B. A., & Patterson, R. E. (2018) · Cancer · doi:10.1002/cncr.30987 · Cited by 188
Oxidative Stress and Cognitive Alterations Induced by Cancer Chemotherapy Drugs: A Scoping Review
Cauli, O. (2021) · Antioxidants · doi:10.3390/antiox10071116 · Cited by 60
Myers, J. S., Erickson, K. I., Sereika, S. M., & Bender, C. M. (2018) · Cancer Nursing · doi:10.1097/ncc.0000000000000549 · Cited by 50
Park, J.-H., Jung, Y. S., Jung, Y.-M., & Bae, S. H. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-018-4546-x · Cited by 43
Bilenduke, E., Sterrett, J. D., Ranby, K. W., Borges, V. F., Grigsby, J., Carr, A. L., Kilbourn, K., & Lowry, C. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-23793-7 · Cited by 39
Jakovljevic, K., Kober, K. M., Block, A., Cooper, B. A., Paul, S. M., Hammer, M. J., Cartwright, F., Conley, Y. P., Wright, F., Dunn, L. B., et al. (2021) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2020.07.019 · Cited by 32
Feng, L. R., Espina, A., & Saligan, L. N. (2018) · Oncology · doi:10.1159/000487081 · Cited by 24
Haller, O. J., Semendric, I., George, R. P., Collins-Praino, L. E., & Whittaker, A. L. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105120 · Cited by 13
Rini, C., Vu, M. B., Lerner, H., Bloom, C., Carda-Auten, J., Wood, W. A., Basch, E. M., Voorhees, P. M., Reeder-Hayes, K. E., & Keefe, F. J. (2018) · Palliative and Supportive Care · doi:10.1017/s1478951517000086 · Cited by 7
Kuil, L. E., Varkevisser, T. M. C. K., Huisman, M. H., Jansen, M., Bunt, J., Compter, A., Ket, H., Schagen, S. B., Meeteren, A. Y. N. S.-V., & Partanen, M. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105514 · Cited by 4
Metadata
- Authors
- Janelsins, M. C., Kesler, S. R., Ahles, T. A., & Morrow, G. R.
- Venue
- International Review of Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2014-02
- Volume
- 26
- Issue
- 1
- Pages
- 102-113
- ISSN
- 0954-0261 (ISSN-L)
- 1369-1627
- OpenAlex
- W2098192159
- Cited by
- 745
- References
- 3
- FWCI
- 23.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
